Monte Rosa Therapeutics Cash Flow Statement (2020-2026) | GLUE

Cash Flow Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-102.80M-102.05M-41.16M-64.82M-26.47M-27.32M-30.78M-32.04M-35.18M-34.88M-33.25M-31.98M-30.31M-23.86M30.73M46.88M-12.29M-27.08M-29.49M-44.55M
Depreciation and Depletion (Quarter)
0.40M0.60M0.83M0.75M0.89M1.03M1.02M1.20M1.39M1.83M1.85M1.90M2.06M2.10M2.06M2.05M2.12M2.10M2.09M2.03M
Share-based Compensation (Quarter)
1.02M26.10M1.86M2.25M35.50M0.20M3.33M3.97M0.10M33.10M4.07M4.87M4.50M4.28M4.47M5.30M4.89M4.36M4.31M49.40M
Cash from Operations (Quarter)
-13.58M-17.79M-14.17M-27.40M-20.50M-20.60M-23.96M-23.41M-25.32M-24.71M29.63M-38.16M-27.77M-20.99M128.92M-45.49M-34.72M100.43M-43.01M-37.37M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)
0.40M0.60M0.83M0.75M0.89M1.03M1.02M1.20M1.39M1.83M1.85M1.90M2.06M2.10M2.06M2.05M2.12M2.10M2.09M2.03M
Change in Working Capital
Change in Account Payables (Quarter)
-0.29M-4.25M4.74M-2.18M-0.36M1.65M0.15M0.31M-1.00M0.69M5.77M-5.07M0.39M-2.38M13.31M-10.87M-1.10M8.88M-10.61M4.38M
Change in Accured Expenses (Quarter)
1.58M5.88M-0.14M-3.56M1.36M1.16M2.07M-3.29M2.77M2.79M1.29M-3.89M2.04M2.33M3.70M-2.61M-2.47M4.19M8.73M-3.71M
Other Working Capital Changes (Quarter)
-2.04M2.26M-0.89M0.61M0.08M1.43M0.01M-0.55M0.23M50.31M2.29M0.95M-9.22M89.35M0.00M-106.91M110.22M-3.91M2.92M
Investing Activities
Capital Expenditures (Quarter)
-1.04M1.79M-1.25M0.79M0.14M3.81M8.16M9.18M6.51M-14.42M17.77M0.98M2.42M0.40M-3.75M0.30M2.98M-2.84M-0.29M2.74M
Sales of Property, Plant and Equipment (Quarter)
0.01M0.12M-0.02M0.06M
Change in Acquisitions & Divestments (Quarter)
130.30M-130.30M45.63M31.07M-31.07M119.67M67.31M14.82M70.52M37.25M39.37M46.05M104.76M89.36M72.87M
Cash from Investing Activities (Quarter)
-2.70M-1.69M-3.05M-180.52M-14.25M29.49M-53.94M20.33M18.55M35.63M14.30M9.85M-61.16M37.75M-30.90M-100.23M25.32M38.14M-65.07M-261.00M
Financing Activities
Other financing activities (Quarter)
0.13M-0.13M0.15M0.10M-0.25M0.44M0.02M0.28M1.71M0.01M0.25M49.75M-49.32M0.38M0.01M-0.01M0.36M5.36M4.52M
Cash from Financing Activities (Quarter)
205.47M29.46M-0.14M0.15M0.10M-0.22M20.43M0.02M1.20M1.10M25.17M0.25M98.02M0.01M0.61M0.01M0.36M0.35M29.62M328.33M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
-143.00M13.51M6.55M24.25M
Additional items
Change in Cash (Quarter)
189.19M9.97M-17.35M-207.77M-34.65M8.67M-57.47M-3.06M-5.57M12.02M69.10M-28.07M9.10M16.77M98.63M-145.71M-9.03M138.91M-78.46M29.97M
Free Cash Flow (Quarter)
-12.54M-19.58M-12.92M-28.20M-20.65M-24.41M-32.12M-32.59M-31.84M-10.28M11.86M-39.15M-30.19M-21.39M132.68M-45.80M-37.70M103.27M-42.72M-40.10M
Net Cash Flow (Quarter)
189.19M9.97M-17.35M-207.77M-34.65M8.67M-57.47M-3.06M-5.57M12.02M69.10M-28.07M9.10M16.77M98.63M-145.71M-9.03M138.91M-78.46M29.97M